Image For Activity Cover
The Past, Present, and Future of Intravenous Platelet Inhibition in the Catheterization Laboratory
Faculty and Program
Srihari Naidu, MD, FSCAI
Megha Prasad, MD
A Deep Dive of the CHAMPION Trials 

Nadia Sutton, MD, MPH, FSCAI
Real World and On-Going Studies of IV Platelet Inhibition


Peter Monteleone, MD, FSCAI
Case Presentation of Heavy Thrombus Burden

Binita Shah, MD, FSCAI

Jay Giri, MD, FSCAI
Acknowledgement of Commercial Support
This activity is supported by an unrestricted educational grant from Chiesi.
Learning Objectives

Upon completion of this activity, participants will be able to:

  • Review trial data supporting the use of IV P2Y12 Inhibitor therapy
  • Examine registry data and on-going trials regarding IV P2Y12 inhibitor therapy use in the cath lab
  • Discuss the application of pharmacotherapy in treating high clot burden
Accredited Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the 
Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

​Credit Designation
SCAI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.0 MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

© 2023-2024 Society for Cardiovascular Angiography and Interventions (SCAI). All rights reserved.
Availability: On-Demand
Access expires on 07/31/2024
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
1 Participation Credit
Powered By